Patents by Inventor Robert A. Newman

Robert A. Newman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11408297
    Abstract: An air seal assembly for a gas turbine includes a flow path platform. The air seal assembly further includes a casing disposed radially outside the flow path platform. The air seal assembly further includes an annular finger seal mounted to the casing and disposed between the flow path platform and the casing. The annular finger seal includes a first circumferential portion mounted to the casing, a second circumferential portion extending from the first circumferential portion, and a third circumferential portion extending from the second circumferential portion and contacting an outer surface of the flow path platform. The third circumferential portion includes a plurality of air cooling holes configured to direct a cooling air stream onto the flow path platform.
    Type: Grant
    Filed: January 12, 2021
    Date of Patent: August 9, 2022
    Inventors: Jeffrey J. Lienau, Robert Newman, Conway Chuong, Kristin Kopp-Vaughan, Senthil Prasad Mathiyalagan, Krishna Nelanti, Rajendra Prasad Uppara Allabanda
  • Patent number: 11369679
    Abstract: The invention features multi-specific protein complexes with one domain comprising IL-15 or a functional variant and a binding domain specific to a disease antigen, immune checkpoint or signaling molecule.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: June 28, 2022
    Assignee: Altor Bioscience, LLC
    Inventors: Hing C. Wong, Warren Marcus, Bai Liu, Wenxin Xu, Robert Newman, Karen Kage, Lijing You, Peter Rhode, Patrick Soon-Shiong
  • Patent number: 11363845
    Abstract: The present invention provides a lightweight glove for baseball or softball that may include an elastic backfinger to provide a conforming fit to the wearer's hand. In general, the elastic backfinger may replace existing, often leather backfingers, the back panel, the liner, and/or other elements of traditional gloves glove with the elastic material, combination of elastic materials, or combination of elastic and inelastic materials.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: June 21, 2022
    Assignee: RAWLINGS SPORTING GOODS COMPANY, INC.
    Inventors: Robert Newman, Anton Sutovsky
  • Publication number: 20220160741
    Abstract: A method of treating viral infection, such as viral infection caused by a virus of the Coronaviridae family, is provided. A composition having at least oleandrin or digoxin is used to treat the viral infection or the disease state of said viral infection.
    Type: Application
    Filed: December 17, 2021
    Publication date: May 26, 2022
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. NEWMAN, Otis C. ADDINGTON, Jose R. Matos, RICHARD J. OBISO
  • Patent number: 11331291
    Abstract: A method of treating a triterpene-responsive condition, disease or disorder in a subject by administration of an improved triterpene-based composition is provided. An improved triterpene-based composition comprising at least two or at least three triterpenes present at a molar ratio as described herein is also provided.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: May 17, 2022
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington, Donald C. Lo, Linda S. Kaltenbach, Peiying Yang
  • Patent number: 11324789
    Abstract: A method of treating equine encephalitis is provided. A composition having at least one cardiac glycoside, such as oleandrin, is used to treat a viral infection causing the encephalitis. The composition can further include at least one triterpene. Alternatively, the composition comprises at least one, at least two, or at least three triterpenes.
    Type: Grant
    Filed: August 18, 2021
    Date of Patent: May 10, 2022
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington
  • Publication number: 20220062399
    Abstract: The invention features multi-specific fusion protein complexes with one domain comprising IL-15 or a functional variant and a binding domain specific to IL-12 or IL-18.
    Type: Application
    Filed: September 27, 2021
    Publication date: March 3, 2022
    Inventors: Warren D. Marcus, Robert Newman, Bai Liu, Lijing You, Lin Kong, Peter Rhode, Hing C. Wong
  • Publication number: 20220054521
    Abstract: A method of treating viral infection, such as viral infection caused by a virus of the Coronaviridae family, is provided. A composition having at least oleandrin is used to treat viral infection.
    Type: Application
    Filed: September 13, 2021
    Publication date: February 24, 2022
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. NEWMAN, Otis C. ADDINGTON, Jose R. MATOS
  • Publication number: 20220047616
    Abstract: A method of treating HTLV-1 virus infection. A composition having at least one cardiac glycoside is used to treat viral infection. The composition can further include at least one triterpene. Alternatively, the composition comprises the combination of at least one cardiac glycoside and at least one, at least two, or at least three triterpenes.
    Type: Application
    Filed: October 27, 2021
    Publication date: February 17, 2022
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. NEWMAN, Otis C. ADDINGTON
  • Publication number: 20220031784
    Abstract: A method of treating equine encephalitis is provided. A composition having at least one cardiac glycoside, such as oleandrin, is used to treat a viral infection causing the encephalitis. The composition can further include at least one triterpene. Alternatively, the composition comprises at least one, at least two, or at least three triterpenes.
    Type: Application
    Filed: August 18, 2021
    Publication date: February 3, 2022
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. NEWMAN, Otis C. ADDINGTON
  • Patent number: 11129883
    Abstract: The invention features multi-specific fusion protein complexes with one domain comprising IL-15 or a functional variant and a binding domain specific to IL-12 or IL-18.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: September 28, 2021
    Assignee: Altor BioScience, LLC.
    Inventors: Warren D. Marcus, Robert Newman, Bai Liu, Lijing You, Lin Kong, Peter Rhode, Hing C. Wong
  • Patent number: 11123387
    Abstract: A method of treating viral infection, such as viral infection caused by a virus of the Filoviridae family, Flaviviridae family (Flavivirus genus), Deltaretrovirus genus, or Togaviriade family is provided. A composition having at least one cardiac glycoside is used to treat viral infection. The composition can further include at least one triterpene. Alternatively, the composition comprises at least one, at least two, or at least three triterpenes.
    Type: Grant
    Filed: February 27, 2020
    Date of Patent: September 21, 2021
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington
  • Publication number: 20210281678
    Abstract: Methods and apparatus are described for a telephony server screening voice calls. In one embodiment, the telephony server receives, form an originating device, an incoming call to be routed to a receiving device. The server answers the incoming call to establish a communication link with the originating device. The server transmits, via the communication link, a challenge audio signal containing an audio message for playback by the originating device. The server receives, via the communication link, a response from the originating device, and, in response to authenticating the response, routes the incoming call to the receiving device. Other embodiments are also described and claimed.
    Type: Application
    Filed: March 6, 2020
    Publication date: September 9, 2021
    Inventors: Alan M. Vale, Robert Newman, Anton Makarenko
  • Publication number: 20210267920
    Abstract: A method of treating a triterpene-responsive condition, disease or disorder in a subject by administration of an improved triterpene-based composition is provided. An improved triterpene-based composition comprising at least two or at least three triterpenes present at a molar ratio as described herein is also provided.
    Type: Application
    Filed: March 8, 2021
    Publication date: September 2, 2021
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: ROBERT A. NEWMAN, OTIS C. ADDINGTON, DONALD C. LO, LINDA S. KALTENBACH, PEIYING YANG
  • Publication number: 20210246832
    Abstract: Flow diverters for installation in mid-turbine frame systems at a conduit outlet of gas turbine engines are described. The flow diverters include a diverter body having a connector portion defining a diverter inlet, a diverter extension at least partially defining a diverter outlet, and a curved portion arranged between the connector portion and the diverter extension, the curved portion configured to change a direction of flow from a first direction to a second direction that is about 90° from the first direction as the flow passes from the diverter inlet to the diverter outlet.
    Type: Application
    Filed: January 22, 2021
    Publication date: August 12, 2021
    Inventors: John S. Tu, Robert Newman, Paul K. Sanchez, Jeffrey J. Lienau, John T. Ols, Prabaharan Manoharan, Venu Sambarapu, Rajendra Prasad Uppara Allabanda
  • Publication number: 20210231023
    Abstract: An air seal assembly for a gas turbine includes a flow path platform. The air seal assembly further includes a casing disposed radially outside the flow path platform. The air seal assembly further includes an annular finger seal mounted to the casing and disposed between the flow path platform and the casing. The annular finger seal includes a first circumferential portion mounted to the casing, a second circumferential portion extending from the first circumferential portion, and a third circumferential portion extending from the second circumferential portion and contacting an outer surface of the flow path platform. The third circumferential portion includes a plurality of air cooling holes configured to direct a cooling air stream onto the flow path platform.
    Type: Application
    Filed: January 12, 2021
    Publication date: July 29, 2021
    Inventors: Jeffrey J. Lienau, Robert Newman, Conway Chuong, Kristin Kopp-Vaughan, Senthil Prasad Mathiyalagan, Krishna Nelanti, Rajendra Prasad Uppara Allabanda
  • Patent number: 11013776
    Abstract: A method of treating viral infection, such as viral infection caused by a virus of the Filoviridae family, Flaviviridae family (Flavivirus genus), Deltaretrovirus genus, or Togaviriade family is provided. A composition having at least one cardiac glycoside is used to treat viral infection. The composition can futher include at least one triterpene. Alternatively, the composition comprises at least one, at least two, or at least three triterpenes.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: May 25, 2021
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington
  • Patent number: 11007239
    Abstract: A method of treating viral infection, such as viral infection caused by a virus of the Filoviridae family, Flaviviridae family (Flavivirus genus), Deltaretrovirus genus, or Togaviriade family is provided. A composition having at least one cardiac glycoside is used to treat viral infection. The composition can further include at least one triterpene. Alternatively, the composition comprises at least one, at least two, or at least three triterpenes.
    Type: Grant
    Filed: January 21, 2020
    Date of Patent: May 18, 2021
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington
  • Patent number: 10980852
    Abstract: A method of treating viral infection, such as viral infection caused by a virus of the Filoviridae family, Flaviviridae family (Flavivirus genus), Deltaretrovirus genus, or Togaviriade family is provided. A composition having at least one cardiac glycoside is used to treat viral infection. The composition can further include at least one triterpene. Alternatively, the composition comprises at least one, at least two, or at least three triterpenes.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: April 20, 2021
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington
  • Patent number: 10973785
    Abstract: A method of treating a triterpene-responsive condition, disease or disorder in a subject by administration of an improved triterpene-based composition is provided. An improved triterpene-based composition comprising at least two or at least three triterpenes present at a molar ratio as described herein is also provided.
    Type: Grant
    Filed: June 8, 2020
    Date of Patent: April 13, 2021
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington, Donald C. Lo, Linda S. Kaltenbach